European Markets for Bone Graft Substitute Products for Spinal Fusion

The European market for bone graft substitute products for spinal fusion, as covered by the scope of this report, includes demineralized bone matrix (DBM), synthetic bone graft substitutes, and recombinant human (rh) bone morphogenetic protein (BMP) products. Bone graft substitutes are used in spinal fusion procedures to increase the probability of a successful fusion. Spine surgeons have several bone graft options to choose from including allograft, autograft, BMP, DBM, synthetic bone grafts, or a combination of these products.